Cite
HARVARD Citation
Raje, N. et al. (2022). Real-world evidence for carfilzomib dosing intensity on overall survival and treatment progression in multiple myeloma patients. Journal of oncology pharmacy practice. pp. 1130-1139. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Raje, N. et al. (2022). Real-world evidence for carfilzomib dosing intensity on overall survival and treatment progression in multiple myeloma patients. Journal of oncology pharmacy practice. pp. 1130-1139. [Online].